Financials

News Discussions Technicals Seasonals

NNG fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

NanoGroup SA engages in the medical research and development. It develops diagnostic, therapeutic and rehabilitation tools for oncology patients. The company's projects include Nanovelos, NanoSanguis and NanoTHEA. NanoGroup was founded by Tomasz Adam Ciach on December 2, 2016 and is headquartered Warsaw, Poland.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

NNG does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company